Accurate Hormone Testing
Image For Activity Cover
4 Courses
Credit Offered
No Credit Offered
  • Course Description
  • Target Audience
  • Program Schedule
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

Welcome to Accurate Hormone Testing, a new 4-part course from Endocrine Society and the Partnership for the Accurate Testing of Hormones (PATH) exploring the endocrinologist’s main tool, hormone assays. This course, developed with support from the National Association of Chronic Disease Directors, seeks to educate fellows and endocrinologists on the importance of, and methods to ensure, accurate hormone testing.

This 4-module course focuses on different aspects of accurately testing and reading hormone assays. Each module will include a didactic lecture, examples, and case-based questions to test your knowledge. Module 1 focuses on the importance of hormone measurements and assay standardization. Module 2 focuses on hormone types and characteristics of an ideal assay. Module 3 focuses on methods used to measure hormones and validation/judging the quality of an assay. The final module explores factors affecting the interpretation of hormone concentrations. 

This program will be of substantial interest to endocrinology fellows, early-career providers, and endocrinologists interested in learning more about hormone standardization.
  • Module 1: The Importance of Hormone Measurement and Assay Standardization
    • Faculty: Alvin Matsumoto, MD 
  • Module 2: Hormone Types and Characteristics of an Ideal Assay
    • Faculty: Christina Wang, MD; Frank Stanczyk, MD
  • Module 3: Methods Used to Measure Hormones and Validation and Judging the Quality of an Assay
    • Faculty: Kyle Lund, PhD; Nanette Santoro, MD 
  • Module 4: Factors Affecting Interpretation of Hormone Concentrations for Diagnosis of Endocrine Disease
    • Faculty: John Fuqua, MD 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Credit is available until July 31, 2023.

Alvin M. Matsumoto, MD
University of Washington School of Medicine
VA Puget Sound Health Care System

Kyle Lund, PhD
University of California, San Diego

Christina Wang, MD
The Lundquist Institute at Harbor - UCLA Medical Center

Frank Stanczyk, PhD
University of Southern California, Keck School of Medicine

Nanette Santoro, MD
University of Colorado School of Medicine

John Fuqua, MD
Indiana University School of Medicine

Hubert Vesper, PhD - Peer Reviewer

Robert Fitzgerald, PhD - Peer Reviewer
University of California, San Diego

Alvin M. Matsumoto, MD - Peer Reviewer
University of Washington School of Medicine
VA Puget Sound Health Care System

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

This educational activity is supported by the Endocrine Society and the National Association of Chronic Disease Directors Partnership to Improve Laboratory Measurements of Chronic Disease Biomarkers project. 

The Partnership to Improve Laboratory Measurements of Chronic Disease Biomarkers project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $100,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.


     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By